Chlamydia Infection Diagnostics Market size was USD 1.6 billion in 2024 and is estimated to reach USD 4.1 billion by the end of 2037, expanding at a CAGR of 7.5% during the forecast period, i.e., 2025-2037. In 2025, the industry size of chlamydia infection diagnostics will be valued at USD 1.7 billion.
Chlamydia is asymptomatic and many young individuals are unaware of STDs and associated risks. This lack of awareness contributes to its higher transmission rates, fuelling the need for advanced chlamydia infection diagnostic solutions. As the prevalence rate increases, the need for effective diagnostic solutions to identify and treat infections promptly booms. This demand drives innovation and investment in chlamydia testing technologies.
For instance, according to the World Health Organization (WHO), around 128.5 million new chlamydia infection cases were registered among the age group of 15 to 49 across the world, in 2022. Particularly for this demographic, the prevalence rate among women was 4.0% and 2.5% in men. Untreated chlamydia can cause serious issues such as HIV or other STIs. To minimize the prevalence rate of chlamydia, public and private healthcare organizations are implementing targeted screening programs and educational campaigns, further boosting the sales of diagnostic solutions.
Growth Drivers:
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
7.5% |
|
Base Year Market Size (2024) |
USD 1.6 billion |
|
Forecast Year Market Size (2037) |
USD 4.1 billion |
|
Regional Scope |
|
Type of Infection (Genital Chlamydia Infection, Rectal Chlamydia Infection, Ocular Chlamydia Infection)
The genital chlamydia infection segment in the chlamydia infection diagnostics market is expected to capture 72.5% of the revenue share by 2037. Genital chlamydia infection occurs due to the direct transmission of agents from person-to-person urogenital tract to the eyes and vice versa occurs via contaminated fingers, towels, or other fomites. The rising prevalence of this infection among adults and adolescents is heightening the need for effective diagnostic tools. The advancements in diagnostic technologies such as nucleic acid amplification tests (NAATs), offer higher sensitivity and specificity making chlamydia testing more reliable.
End use (Hospitals, Speciality Clinics, Diagnostic Centers)
The hospital segment is foreseen to account for 52.5% of the global chlamydia infection diagnostics market share through 2037 owing to the large patient base and first preference of patients for medical care. Hospitals provide a multidisciplinary approach to healthcare. Patients often prefer them for chlamydia testing because they can access various services, including counseling, treatment, and follow-up care, all in one place. The presence of skilled healthcare professionals and staff, who can offer more informed and reliable diagnostic and treatment options coupled with the presence of next-gen diagnostic technologies, which enable more accurate and faster testing for chlamydia are contributing to the segmental growth.
Our in-depth analysis of the chlamydia infection diagnostics market includes the following segments:
|
Test Type
|
|
|
Type of Infection |
|
|
End use |
|
North America Market Forecast
North America is expected to capture 39% share of the global chlamydia infection diagnostics market by 2037 owing to the presence of advanced research organizations and next-gen healthcare facilities. The chlamydia awareness programs and high screening initiatives are also set to fuel the sales of diagnostic solutions and services in the region.
The U.S. chlamydia infection diagnostics market is estimated to reach a valuation of USD 1.5 billion by 2037. The high prevalence of sexually transmitted infections is one of the major drivers pushing the demand for advanced chlamydia infection diagnostic solutions. For instance, according to the Centers for Disease Control and Prevention, in 2022, over 2.5 million cases of gonorrhea, syphilis, and chlamydia were reported in the U.S. These alarming statistics are driving high investments in research and development activities to develop innovative diagnostic and treatment solutions.
Canada is also witnessing rising cases of sexually transmitted infections including chlamydia, promoting a high need for effective diagnostic solutions. The public health organizations in the country are also increasingly focusing on STI prevention, leading to high awareness and demand for testing services. For instance, the Government of Canada has developed an action plan 2024-2030 to mitigate the prevalence of sexually transmitted and blood-borne infections.
Asia Pacific Market Statistics
The Asia Pacific market is anticipated to increase at a rapid pace during the projected period owing to the increasing healthcare expenditures, growing awareness of STIs, and rising entrance of international diagnostic solution manufacturing companies. China and India are the most lucrative marketplaces for key players owing to cost-effective R&D and high investments in healthcare infrastructure development projects. The presence of modern medical facilities and innovative solutions is also driving market growth in Japan and South Korea.
In India, the increasing prevalence rate of STIs including chlamydia is augmenting a high demand for advanced diagnostic solutions. The expanding medical devices and diagnostic equipment markets are also positively influencing the profits of chlamydia infection diagnostic solution manufacturers.
Key players in the chlamydia infection diagnostics market employ several tactics such as new product launches, technological advancements, partnerships and collaborations, regional expansion, and more to earn high profits. Industry giants are investing heavily in research and development activities to introduce innovative diagnostic solutions. Strategic collaborations with other players and research organizations are also aiding them to expand their product folios. Furthermore, regional expansion strategies are helping them to tap into emerging markets to cater to a larger audience base.
Some of the key players include:
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?